← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3281 | 62295-3281-6 | Cyanocobalamin; Choline Chloride; Inositol; Methionine | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-052 | 70713-052-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-345 | 73693-345-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2100 | 70168-2100-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6030 | 71285-6030-1 | Epinephrine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:451 | 451 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Bitartrate; Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:451 | 451 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-32 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-072 | 71449-072-41 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-1 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:451 | 451 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9227 | 71266-9227-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:451 | 451 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1048 | 73013-1048-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:451 | 451 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0420 | 71285-0420-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:452 | 452 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-137 | 73198-137-10 | F-1 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:452 | 452 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin; Choline Chloride; Inositol; Pyridoxine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:452 | 452 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-051 | 70713-051-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:452 | 452 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-350 | 73693-350-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:452 | 452 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2060 | 70168-2060-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:452 | 452 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8093 | 72196-8093-1 | Epinephrine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:452 | 452 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride; Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:452 | 452 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:452 | 452 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-013 | 71449-013-05 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:452 | 452 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-222 | 70004-222-30 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:452 | 452 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2074 | 71286-2074-1 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:452 | 452 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:452 | 452 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:452 | 452 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:452 | 452 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1047 | 73013-1047-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:452 | 452 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0428 | 72196-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate; Methionine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:453 | 453 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2405 | 72627-2405-1 | Ascorbic Acid | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:453 | 453 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin; Tadalafil | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-050 | 70713-050-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2204 | 72627-2204-9 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2090 | 70168-2090-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-813 | 76154-813-15 | Epinephrine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-127 | 71449-127-32 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:453 | 453 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-098 | 70092-098-44 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-200 | 70004-200-32 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:453 | 453 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-1 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-202 | 70092-202-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:453 | 453 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1055 | 73013-1055-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:453 | 453 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:454 | 454 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-402 | 73693-402-01 | TESTOSTERONE 200MG | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:454 | 454 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin; Tadalafil | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-006 | 69761-006-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-346 | 73693-346-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-335 | 73693-335-01 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-814 | 76154-814-15 | Epinephrine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-134 | 71449-134-32 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1013 | 73013-1013-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-100 | 70092-100-50 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-202 | 70004-202-22 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:454 | 454 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-6 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:454 | 454 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:454 | 454 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:454 | 454 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:454 | 454 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0408 | 72196-0408-1 | Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Lysine Acetate; Serine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:455 | 455 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5534 | 72934-5534-4 | Norovo | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:455 | 455 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin; Vitamin D; Ascorbic Acid; Thiamine; Riboflavin; Pyridoxine; Vitamin a Palmitate; Tocopherol; Niacin | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-010 | 69761-010-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-347 | 73693-347-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-345 | 73693-345-01 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-812 | 76154-812-15 | Epinephrine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:455 | 455 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-509 | 70092-509-35 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2074 | 71286-2074-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:455 | 455 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-5 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-104 | 70092-104-36 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:455 | 455 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:455 | 455 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:455 | 455 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5101 | 26436-5101-3 | Glutamine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:456 | 456 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2529 | 72934-2529-2 | Purazil | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:456 | 456 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin; Vitamin D; Ascorbic Acid; Thiamine; Riboflavin; Pyridoxine; Vitamin a Palmitate; Tocopherol; Niacin | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-015 | 69761-015-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-348 | 73693-348-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-346 | 73693-346-01 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8110 | 71266-8110-1 | Epinephrine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:456 | 456 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ergoloid Mesylates; Aminophylline; Arginine; Pentoxifylline | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1016 | 73013-1016-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-444 | 70092-444-05 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-139 | 73177-139-27 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:456 | 456 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6030 | 60652-6030-1 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-105 | 70092-105-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:456 | 456 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:456 | 456 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:456 | 456 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-145 | 73198-145-30 | Glutamine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:457 | 457 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-4011 | 70214-4011-1 | fentaNYL 2 mcg/mL and Bupivacaine 0.125% | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:457 | 457 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin; Vitamin D; Ascorbic Acid; Thiamine; Riboflavin; Pyridoxine; Vitamin a Palmitate; Tocopherol; Niacin; Ferrous Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-020 | 69761-020-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-349 | 73693-349-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2010 | 70168-2010-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-925 | 69374-925-10 | Epinephrine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-620 | 70004-620-12 | Esmolol Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-04 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-099 | 70092-099-49 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-9010 | 60652-9010-1 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-160 | 70092-160-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:457 | 457 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9235 | 71266-9235-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:457 | 457 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:458 | 458 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-123 | 63037-123-25 | Ephedrine Sulfate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:458 | 458 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin; Vitamin D; Ascorbic Acid; Thiamine; Riboflavin; Pyridoxine; Vitamin a Palmitate; Tocopherol; Niacin; Ferrous Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-022 | 69761-022-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2070 | 70168-2070-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-053 | 70713-053-01 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-231 | 70731-231-86 | Epinephrine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1367 | 61141-1367-5 | Esmolol Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-05 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:458 | 458 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-2 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-6 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:458 | 458 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:458 | 458 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9228 | 71266-9228-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4606 | 72934-4606-8 | Finasteride; Minoxidil | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:458 | 458 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-049 | 73198-049-30 | Glutathione | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:459 | 459 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9076 | 83826-9076-5 | Cyclopentolate HCl, Tropicamide, Phenylephrine HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:459 | 459 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclobenzaprine Hydrochloride; Gabapentin; Lidocaine; Baclofen; Flurbiprofen | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-025 | 69761-025-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2050 | 70168-2050-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-350 | 73693-350-01 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-544 | 69374-544-10 | Epinephrine Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0025 | 73271-0025-1 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-16 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:459 | 459 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6030 | 60652-6030-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5050 | 71266-5050-1 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:459 | 459 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:459 | 459 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9227 | 71266-9227-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4599 | 72934-4599-8 | Finasteride; Minoxidil | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:459 | 459 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-049 | 73198-049-05 | Glutathione | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:460 | 460 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:460 | 460 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclobenzaprine Hydrochloride; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-018 | 69761-018-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 77437-024 | 77437-024-25 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:460 | 460 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride; Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0375 | 73271-0375-1 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-07 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:460 | 460 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2073 | 71286-2073-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:460 | 460 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9228 | 71266-9228-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9225 | 71266-9225-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4607 | 72934-4607-8 | Finasteride; Tretinoin; Minoxidil | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:460 | 460 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4520 | 72682-4520-1 | Glutathione | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:461 | 461 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | ESTRADIOL 6 PEL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0945 | 5446-0945-01 | Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride; Ketorolac Tromethamine; Ciprofloxacin Hydrochloride; Tropicamide | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-012 | 69761-012-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2060 | 70168-2060-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 77437-026 | 77437-026-25 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:461 | 461 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0015 | 73271-0015-1 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:461 | 461 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-180 | 70092-180-79 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2081 | 71286-2081-1 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-3 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:461 | 461 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1023 | 73013-1023-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2630 | 72934-2630-2 | Fluorouracil; Calcipotriene | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:461 | 461 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4587 | 72682-4587-1 | Glutathione | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:462 | 462 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-040 | 68985-040-94 | Phenylephrine HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0996 | 5446-0996-01 | Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride; Ketorolac Tromethamine; Ciprofloxacin Hydrochloride; Tropicamide | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2090 | 70168-2090-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 77437-023 | 77437-023-25 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:462 | 462 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2204 | 72627-2204-9 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:462 | 462 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-04 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:462 | 462 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1014 | 73013-1014-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:462 | 462 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-135 | 69194-135-01 | Foscarnet Sodium | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:462 | 462 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:463 | 463 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5016 | 71266-5016-2 | Norepinephrine Bitartrate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:463 | 463 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1334 | 5446-1334-01 | Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride; Tropicamide | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:463 | 463 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:463 | 463 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:463 | 463 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 77437-025 | 77437-025-25 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:463 | 463 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:463 | 463 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | Estradiol | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:463 | 463 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-01 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:463 | 463 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-092 | 70092-092-36 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 |